Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR): $13.43

0.14 (+1.05%)

POWR Rating

Component Grades

Buy & Hold




Add CNCR to Watchlist
Sign Up

Category: Health & Biotech ETFs




#34 of 42

in category

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $13.43 52-week high $18.01
Prev. close $13.29 52-week low $11.68
Day low $13.23 Volume 1,900
Day high $13.50 Avg. volume 7,563
50-day MA $12.77 Dividend yield N/A
200-day MA $14.13

CNCR Stock Price Chart Interactive Chart >

Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio

The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.


Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Underlying Index Loncar Cancer Immunotherapy Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 16.79M
Net Asset Value (NAV) $13.43
Options? Yes
Total Holdings 32

CNCR Price Returns

1-mo 2.05%
3-mo 0.00%
6-mo -10.82%
1-year -3.21%
3-year -45.63%
5-year -48.86%
YTD -2.18%
2022 -42.31%
2021 -19.24%
2020 36.53%
2019 24.22%
2018 -20.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!